GlaxoSmithKline, University of Oxford join forces in $40M digital deep dive into neuro

Major U.K. Big Pharma GlaxoSmithKline and leading academic center the University of Oxford have penned a new five-year research collab deal focused on making smarter bets on so-called “digital biology.”